Literature DB >> 17611083

Heterogeneity in retinoic acid signaling in neuroblastomas: Role of matrix metalloproteinases in retinoic acid-induced differentiation.

Suchitra Joshi1, Rakeshwar S Guleria, Jing Pan, Donald Dipette, Ugra S Singh.   

Abstract

Causes of retinoid resistance often observed in neuroblastomas are unknown. We studied all trans-retinoic acid (RA) signaling in neuroblastoma cells differing in N-myc levels in terms of neurite formation, expression of tissue transglutaminase, neuronal marker proteins, matrix metalloproteinases (MMPs), and activation of Rac1 and Cdc42. Poor invasiveness observed in SH-SY5Y, LA-N-5, and SMS-KCNR cells was associated with RA-induced neurite formation, Cdc42 activation and N-myc down regulation; expression of constitutively active Cdc42 down regulated N-myc expression and reduced invasion in RA-resistant SK-N-BE(2) and IMR32 cells. RA treatment for 24 h transiently increased invasion and expression of MMP9 in SH-SY5Y, LA-N-5 and MMP2 in SMS-KCNR cells. MMP inhibition prevented RA-induced neurite formation indicating a role in differentiation. Variation in RA signaling thus follows a defined pattern and relates to invasive potential. A defective RA signaling might result in retinoid resistance and unpredictable clinical outcome observed in some neuroblastomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611083     DOI: 10.1016/j.bbadis.2007.05.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Closing the phenotypic gap between transformed neuronal cell lines in culture and untransformed neurons.

Authors:  Tereance A Myers; Cheryl A Nickerson; Deepak Kaushal; C Mark Ott; Kerstin Höner zu Bentrup; Rajee Ramamurthy; Mayra Nelman-Gonzalez; Duane L Pierson; Mario T Philipp
Journal:  J Neurosci Methods       Date:  2008-07-10       Impact factor: 2.390

2.  Peroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.

Authors:  Pei-Li Yao; Liping Chen; Tomasz P Dobrzański; Bokai Zhu; Boo-Hyon Kang; Rolf Müller; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Carcinog       Date:  2017-01-13       Impact factor: 4.784

3.  Targeting Notch pathway induces growth inhibition and differentiation of neuroblastoma cells.

Authors:  Giulia Ferrari-Toninelli; Sara Anna Bonini; Daniela Uberti; Laura Buizza; Paola Bettinsoli; Pietro Luigi Poliani; Fabio Facchetti; Maurizio Memo
Journal:  Neuro Oncol       Date:  2010-08-17       Impact factor: 12.300

4.  MYCN Silencing by RNAi Induces Neurogenesis and Suppresses Proliferation in Models of Neuroblastoma with Resistance to Retinoic Acid.

Authors:  Ruhina Maeshima; Dale Moulding; Andrew W Stoker; Stephen L Hart
Journal:  Nucleic Acid Ther       Date:  2020-04-02       Impact factor: 5.486

5.  Targeting angiogenesis for controlling neuroblastoma.

Authors:  Subhasree Roy Choudhury; Surajit Karmakar; Naren L Banik; Swapan K Ray
Journal:  J Oncol       Date:  2011-08-25       Impact factor: 4.375

6.  Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells.

Authors:  Vasantha Kumar Bhaskara; Indra Mohanam; Jasti S Rao; Sanjeeva Mohanam
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

7.  Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling.

Authors:  Mario Nizzari; Stefano Thellung; Alessandro Corsaro; Valentina Villa; Aldo Pagano; Carola Porcile; Claudio Russo; Tullio Florio
Journal:  J Toxicol       Date:  2012-02-08

8.  Exendin-4 induces cell adhesion and differentiation and counteracts the invasive potential of human neuroblastoma cells.

Authors:  Paola Luciani; Cristiana Deledda; Susanna Benvenuti; Roberta Squecco; Ilaria Cellai; Benedetta Fibbi; Ilaria Maddalena Marone; Corinna Giuliani; Giulia Modi; Fabio Francini; Gabriella Barbara Vannelli; Alessandro Peri
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240

9.  Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway.

Authors:  Brendan D Looyenga; James Resau; Jeffrey P MacKeigan
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

10.  All-Trans Retinoic Acid Induces TGF-β2 in Intestinal Epithelial Cells via RhoA- and p38α MAPK-Mediated Activation of the Transcription Factor ATF2.

Authors:  Kopperuncholan Namachivayam; Krishnan MohanKumar; Dima Arbach; Ramasamy Jagadeeswaran; Sunil K Jain; Viswanathan Natarajan; Dolly Mehta; Robert P Jankov; Akhil Maheshwari
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.